logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Nuo Wei Zan's (688105.SH) subsidiary's product has obtained a medical device registration certificate.

date
24/09/2025
China Finance APP news, Nuoweizan (688105.SH) has announced that the several neurosystem series diagnostic reagents developed by its wholly-owned subsidiary, Nanjing Nuoweizan Medical Technology Co., Ltd., have recently obtained multiple "Medical Device Registration Certificates" in China.
Latest
1 m ago
Raymond James raised the price target for Micron Technology from $150 to $190.
2 m ago
The USD/JPY rose by 0.5% to 148.425.
2 m ago
The consortium composed of RWE and TotalEnergies has won the bid for the French wind farm project, and will construct and operate Centre Manche 2.
2 m ago
Space concept stock Redwire rose more than 4% in pre-market trading, with a nearly 14% surge overnight after announcing the delivery of unmanned drone systems to the Ukrainian armed forces; Sol Industry rose nearly 7% with fourth quarter revenue and earnings per share exceeding expectations.
2 m ago
Hengshuo shares (688416.SH) plans to launch a restricted stock incentive plan for 1,079,000 shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.